Review: taking Meloxicam and Prednisone together


Summary

Drug interactions are reported among people who take Meloxicam and Prednisone together. This review analyzes the effectiveness and drug interactions between Meloxicam and Prednisone. It is created by eHealthMe based on reports of 2,355 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Meloxicam and Prednisone >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Meloxicam

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. (latest outcomes from Meloxicam 13,699 users)

Prednisone

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. (latest outcomes from Prednisone 176,486 users)

On Aug, 25, 2016

2,355 people who take Meloxicam, Prednisone are studied.


Number of reports submitted per year:

Meloxicam and Prednisone drug interactions.

Drug effectiveness over time:

Meloxicam:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 28.0% - (2 of 7 people)
  • 6 - 12 months: 33.0% - (2 of 6 people)
  • 1 - 2 years: 25.0% - (2 of 8 people)
  • 2 - 5 years: 16.0% - (1 of 6 people)
  • 5 - 10 years: 0.0% - (0 of 6 people)
  • 10+ years: 100.0% - (2 of 2 people)
  • not specified: 0.0% - (0 of 1 people)
Prednisone:
  • < 1 month: 14.0% - (1 of 7 people)
  • 1 - 6 months: 62.0% - (5 of 8 people)
  • 6 - 12 months: 66.0% - (4 of 6 people)
  • 1 - 2 years: 0.0% - (0 of 6 people)
  • 2 - 5 years: 33.0% - (2 of 6 people)
  • 5 - 10 years: 60.0% - (3 of 5 people)
  • 10+ years: 50.0% - (2 of 4 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Meloxicam:
  • female: 28.0% - (7 of 25 people)
  • male: 14.0% - (2 of 14 people)
Prednisone:
  • female: 50.0% - (14 of 28 people)
  • male: 21.0% - (3 of 14 people)

Drug effectiveness by age:

Meloxicam:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 25.0% - (1 of 4 people)
  • 30-39: 0.0% - (0 of 4 people)
  • 40-49: 16.0% - (1 of 6 people)
  • 50-59: 23.0% - (3 of 13 people)
  • 60+: 36.0% - (4 of 11 people)
Prednisone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 40.0% - (2 of 5 people)
  • 30-39: 25.0% - (1 of 4 people)
  • 40-49: 42.0% - (3 of 7 people)
  • 50-59: 21.0% - (3 of 14 people)
  • 60+: 63.0% - (7 of 11 people)

Most common drug interactions over time *:

< 1 month:
  • pain
  • fatigue
  • pyrexia
  • dyspnoea
  • headache
  • arthralgia
  • fall
  • somnolence
  • nausea
  • urticaria
1 - 6 months:
  • diabetes mellitus
  • pneumocystis jiroveci pneumonia
  • urinary tract infection
  • atrial fibrillation
  • cardiac failure congestive
  • pain
  • anxiety
  • migraine
  • transverse sinus thrombosis
  • abortion induced
6 - 12 months:
  • cardiac failure congestive
  • diabetes mellitus
  • urinary tract infection
  • atrial fibrillation
  • cardiomegaly
  • choledochal cyst
  • cyanosis neonatal
  • neonatal respiratory distress syndrome
  • pulmonary artery atresia
  • pulmonary valve stenosis
1 - 2 years:
  • back pain
  • pyrexia
  • nausea
  • headache
  • mouth ulceration
  • abdominal pain
  • acute interstitial pneumonitis
  • aortic valve incompetence
  • asthenia
  • atelectasis
2 - 5 years:
  • transient ischaemic attack
  • candidiasis
  • decreased appetite
  • nausea
  • pyrexia
  • weight decreased
  • abdominal pain
  • alanine aminotransferase increased
  • anaemia
  • aspartate aminotransferase increased
5 - 10 years:
  • early morning joint stiffness
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • lung neoplasm
  • coronary artery disease
  • abdominal pain lower
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • brain mass
  • chronic pain
  • drug-induced liver injury
10+ years:
  • knee arthroplasty
  • swelling
not specified:
  • pain
  • arthralgia
  • anxiety
  • fatigue
  • nausea
  • dyspnoea
  • oedema peripheral
  • pain in extremity
  • anaemia
  • headache

Most common drug interactions by gender *:

female:
  • pain
  • arthralgia
  • fatigue
  • anxiety
  • nausea
  • oedema peripheral
  • pain in extremity
  • diarrhoea
  • anaemia
  • pyrexia
male:
  • dyspnoea
  • pain
  • arthralgia
  • nausea
  • headache
  • chest pain
  • fatigue
  • anxiety
  • cellulitis
  • pneumonia

Most common drug interactions by age *:

0-1:
  • congenital cystic kidney disease
  • blood cholesterol increased
  • gallbladder operation
  • maternal drugs affecting foetus
  • sensation of foreign body
  • type 2 diabetes mellitus
10-19:
  • pain
  • abdominal pain upper
  • injection site pain
  • contusion
  • fall
  • fatigue
  • headache
  • laceration
  • loss of consciousness
  • rash
20-29:
  • pain
  • anxiety
  • injury
  • acute respiratory distress syndrome
  • depression
  • pericardial effusion
  • toxic epidermal necrolysis
  • vomiting
  • injection site pain
  • fluid overload
30-39:
  • arthralgia
  • pain in extremity
  • back pain
  • injection site pain
  • dehydration
  • arthritis
  • anaemia
  • chest pain
  • diarrhoea
  • electrolyte imbalance
40-49:
  • pain
  • arthralgia
  • fatigue
  • headache
  • anxiety
  • nausea
  • dyspnoea
  • oedema peripheral
  • back pain
  • pain in extremity
50-59:
  • pain
  • arthralgia
  • anxiety
  • anaemia
  • fatigue
  • oedema peripheral
  • spinal osteoarthritis
  • pyrexia
  • bone disorder
  • diarrhoea
60+:
  • pain
  • headache
  • anxiety
  • nausea
  • arthralgia
  • dyspnoea
  • weight decreased
  • pain in extremity
  • osteoarthritis
  • anaemia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Meloxicam and Prednisone?

Can you answer these questions?

More questions for: Meloxicam, Prednisone

You may be interested in these reviews

More reviews for: Meloxicam, Prednisone

On eHealthMe, Meloxicam (meloxicam) is often used to treat arthritis. Prednisone (prednisone) is often used to treat rheumatoid arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.